Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Thoughts from a Shareholder / Investor

IMHO, it is still too early for the BoD to make comments on the Markman. We know the claims that we won and what still needs to be done. Let them have a chance to focus on what needs to be done right now. GL, ads

Share
New Message
Please login to post a reply